Skip to main content
profile image
Selected Works of Daniel Lorch, MD
Article
Solriamfetol for the Treatment of Excessive Sleepiness in OSA: A Placebo-Controlled Randomized Withdrawal Study
Chest (2019)
  • Patrick J. Strollo, University of Pittsburgh
  • Jan Hedner, Sahlgrenska University Hospital
  • Nancy Collop, Emory University
  • Daniel G. Lorch, PAB Clinical Research/Florida Sleep Disorder Center, Brandon, FL
  • Dan Chen, Jazz Pharmaceuticals plc, Palo Alto, CA
  • Lawrence P. Carter, University of Arkansas for Medical Sciences
  • Yuan Lu, Jazz Pharmaceuticals plc, Palo Alto, CA
  • Lawrence Lee, Jazz Pharmaceuticals plc, Palo Alto, CA
  • Jed Black, Stanford University
  • Jean-Louis Pépin, University of Grenoble
  • Susan Redline, Beth Israel Deaconess Medical Center
  • Markku Partinen, Helsinki Sleep Clinic
  • Olli Polo, Unesta Research Center
  • Tarja Saaresranta, University of Turku
  • Christine Paschen
  • Lena Leissner
  • Bradley Block
  • Robert Doekel
  • Stephen Duntley
  • Guillermo Giangreco
  • Rachel Givelber
  • Andrew Krystal
  • Chitra Lal
  • Mitchell Lee
  • James Maynard
  • Daniel Norman
  • Russell Rosenberg
  • Vernon Rowe
  • Kathleen Sarmiento
  • Andrew Schreiber
  • Richard Schwab
  • David Seiden
  • Morteza Shamsnia
  • J. Catesby Ware
Link
Disciplines
Publication Date
February 1, 2019
DOI
10.1016/J.CHEST.2018.11.005
Citation Information
Patrick J. Strollo, Jan Hedner, Nancy Collop, Daniel G. Lorch, et al.. "Solriamfetol for the Treatment of Excessive Sleepiness in OSA: A Placebo-Controlled Randomized Withdrawal Study" Chest Vol. 155 Iss. 2 (2019) p. 364 - 374
Available at: http://works.bepress.com/daniel-lorch/3/